KPJ Healthcare Bhd reports Q4 FY2025 results and full-year performance


KPJ Healthcare Bhd recorded a 9% rise in revenue to RM4.26bil for FY2025, reflecting continued growth in its healthcare operations.

KPJ Healthcare Bhd today announced its financial results for the fourth quarter ended Dec 31, 2025, concluding the group’s performance for the full financial year.

For Q4 FY2025, revenue increased 10% year-on-year to RM1.152bil and 3% quarter-on-quarter. Meanwhile, earnings before interest, taxes, depreciation and amortisation (Ebitda) rose 3% year-on-year and 14% quarter-on-quarter to RM312mil, with margin at 27.1%.

Profit after tax and minority interest (Patami) also strengthened, increasing 10% year-on-year to RM133mil and 42% quarter-on-quarter, with margin at 11.5%.

On the operational front, inpatient admissions grew 3% year-on-year to 99,721, while outpatient visits rose 6% to 773,799 and surgical cases increased 11% to 30,784. In parallel, average revenue per inpatient rose 7% to RM8,379, while average revenue per outpatient increased 1% to RM335. The Bed Occupancy Rate for the quarter was 67%, lower year-on-year but higher quarter-on-quarter.

For the full year FY2025, revenue rose 9% to RM4.26bil, Ebitda increased 6% to RM1.05bil and Patami amounted to RM366mil. During the year, operational beds expanded by 4% year-on-year as capacity growth progressed, while surgical cases rose 11% and average revenue per inpatient increased 7%, reflecting continued patient activity across the network.

Chin: The next phase of KPJ’s growth will be driven by AI and genomics to build a predictive care model where patient outcomes remain the ultimate measure of success.
Chin: The next phase of KPJ’s growth will be driven by AI and genomics to build a predictive care model where patient outcomes remain the ultimate measure of success.

Looking ahead, the board has declared a first interim dividend of 1.35 sen per share for FY2026, totalling RM59.2mil, payable on April 17.

KPJ Healthcare’s president and managing director Chin Keat Chyuan said FY2025 reflected measurable progress in strengthening revenue quality, operating leverage and clinical depth across the group.

“Growth, supported by resilient patient demand, improving case mix and deeper specialist capability, is shifting KPJ toward higher-acuity, value-generative services. Capacity expansion and operational discipline are translating into stronger earnings conversion.

“With the KPJ Health System as our transformation platform, we are strengthening integration, enhancing efficiency and reinforcing our ‘Care for Life’ commitment as we position the group for sustainable long-term growth,” he said.

Alongside its results, KPJ unveiled its 2026–2030 Strategic Plan, marking a structural shift in establishing Malaysia’s first private integrated Academic Health System built on the KPJ Health System (KPJHS).

Under the plan, KPJ will complete integration under ‘One System, One Purpose, One Standard’, anchored by the KPJ Care Network, a hub-and-spoke ecosystem connecting hospitals, specialists and patients nationwide.

Advancing clinical excellence and sustainable growth, KPJ Healthcare remains committed to delivering high-quality care for the communities it serves.
Advancing clinical excellence and sustainable growth, KPJ Healthcare remains committed to delivering high-quality care for the communities it serves.

Growth will be driven by 15 Centres of Excellence (CoEs) in heart and lung, oncology, neuro and stroke, and orthopedics.

Brownfield expansion at nine hospitals will add approximately 2,200 beds. Brownfield expansion is the process of upgrading, repurposing or expanding existing healthcare facilities to modernise outdated structures, improve patient care and enhance operational efficiency.

Over the 2026–2030 period, the Strategic Plan shifts KPJ’s growth model from expansion-led capacity build-out to system-led value creation, with the KPJ Health System and KPJ Care Network at its core.

According to the statement by KPJ, performance will increasingly be driven by higher-acuity clinical depth through CoEs, stronger referral capture and utilisation across the hub-and-spoke network, disciplined brownfield optimisation and Ambulatory Care Centres rollout that enhance revenue intensity and operating leverage.

At the same time, convergence of AI, data, genomics and value-based, predictive, preventive and precision care, reinforced by an academic and research platform and experience-led differentiation, is expected to strengthen pathway economics, margin resilience and long-term shareholder value.

 

 

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Starpicks

Powering nation’s progress: TNB’s FY2025 growth returns value to rakyat
Amway at 50: Why impact is the true measure of success
BUILDING FINANCIAL RESILIENCE AMID RISING COSTS
KPJ SETS NEW DIRECTION FOR HEART AND LUNG CARE
Buyers to reap benefits from Malaysia-assembled MPV
One million Nasi Mekdi meals for varsity youth
KL’s gateway to British education
PERKESO PAYOUTS HIT RM6.65BIL AS WORKER PROTECTION EXPANDS
Cultivating empathy in the medical profession
How AI changes the way people work, learn and play

Others Also Read